Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
about
The inflammatory protein Pentraxin 3 in cardiovascular diseaseThe angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine productionPlasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers.The effect of experimental streptococcus infection in myocarditis on some biochemical and inflammatory markers in albino rats.HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of pentraxin-3 in human plasmaThe Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients.Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndromeAssociations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyPentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies.Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation.Morning pentraxin3 levels reflect obstructive sleep apnea-related acute inflammationInfluence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver diseaseElevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsEmergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage.Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.The cardiokine story unfolds: ischemic stress-induced protein secretion in the heartPentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.Consolidated and emerging inflammatory markers in coronary artery diseasePentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia.Dexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3: potential clinical implications.Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-AmericansAssociations between pentraxin 3 and severity of coronary artery disease.Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stressPentraxin 3: a novel biomarker for inflammatory cardiovascular diseasePentraxin 3(PTX 3): an endogenous modulator of the inflammatory responsePentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.Pattern recognition by pentraxins
P2860
Q26738957-1BF2AF36-FCD6-4BBA-B16C-4842E3C00860Q28118397-6ED775B3-338D-460A-8E3A-6BE7B0ABD1F8Q30319434-151D6EE8-B4DC-4998-9643-C1E777BC47CAQ30640505-55FF36B2-BA4A-4283-909F-80B17669B503Q31057428-76BB7B47-4A9D-4753-9CEA-6C305CC9B529Q33384921-2D8E77B0-07E2-4185-A1D4-13FFA987359FQ33650222-E0F6E967-DA64-4E50-A7AE-A846392A3EBBQ33751531-D18C14D9-109D-40FB-B916-3A20161637CCQ33889411-731309DE-3CDC-480C-B7BF-768D1D55FAC4Q33986610-B50269DB-B797-449A-BBE5-86CC3B8B31BBQ34021175-119BFABA-4BEF-47FC-A678-501839DD4127Q34104578-1189C11C-990D-4AA2-A622-8E5EA881EE5BQ34150807-61C6A434-6A3B-4A2D-86FF-85D62CF3EBEAQ34154838-70153E62-ADCD-4250-BA7E-3D41712F2C87Q34235212-5A2B9E3C-F32C-4AAE-9B21-861838A807A7Q34519002-B099DD74-BE72-4EC1-B0BE-AB5AD7EF91EDQ34534979-F02BE697-895D-4081-85C9-1A83273BD3C3Q34543068-175CAB38-4AF3-44EF-AD76-C8DEBACA3583Q34576441-C8035232-7BF6-48C2-B598-5E99AAD80E4AQ34620837-1479E7C6-821A-42D4-ADB2-BF68E02F0D93Q34630224-AA05FF57-159B-4B0A-A8A0-C4592C07544AQ34713240-E9FF59EF-9E33-4A7E-91AA-9AF23CFFB978Q34714685-F2C022EE-18E6-41C7-BAD7-7C5274DDAA3FQ34722498-5D5E25FA-740C-4B66-9123-C93853721E4EQ34724967-EFCD92EB-2592-46B8-993A-8C021DDFC8B7Q34751855-A4E25E89-5BB0-40B8-8866-3A1358FF446BQ34809985-2643F6E2-EC35-443C-9DA8-9298E6286A0DQ34988829-1D609F12-1C7D-4ECA-BA61-B324D543AAC6Q35019922-444E7FA9-D41C-4238-8D9D-74ECAC857527Q35021428-19F253E8-993F-479B-B52C-4CD139A11F03Q35110197-A6169E63-EB30-4CE8-A82C-8AD1816C20BAQ35133148-8A36C37E-B12D-4EBC-964B-DF0F1FFD4D97Q35140370-1FEEA004-8C47-402C-AF16-DCA370CEC557Q35181453-BB198775-83E5-4637-BB7C-89AAA3E81404Q35332533-F7778D25-55ED-4D62-B91A-3DD54A1825F6Q35422363-BD2DC9A7-AD90-4196-9467-718F1CB6BB81Q35755280-D5A926A3-AC7E-4989-BDEF-EB9DE9054561Q35915482-8BA2E97C-A8B3-42EB-92AE-4FD95804170CQ35924554-C86007D3-AA1C-4F38-8DD7-F133B78CE930Q36008865-1BF7CFB5-B350-4FBA-AD2E-C4A151FD600E
P2860
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@ast
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@en
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@nl
type
label
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@ast
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@en
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@nl
prefLabel
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@ast
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@en
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@nl
P2093
P1433
P1476
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
@en
P2093
Aldo P Maggioni
Carlo Schweiger
Claudio Fresco
Dario Soldateschi
Donata Lucci
Fabio Pasqualini
Gianni Tognoni
Giuseppe Peri
Lipid Assessment Trial Italian Network (LATIN) Investigators
Lorenzo Tarli
P304
P356
10.1161/01.CIR.0000145167.30987.2E
P407
P577
2004-10-11T00:00:00Z